Reviva Pharmaceuticals Holdings Inc. (RVPH)

Reviva Pharmaceuticals Holdings Inc. (RVPH) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $6.5M; returns 1 day -0.2%, 1 week -14.0%, 1 year -96.2%.

Reviva Pharmaceuticals Holdings Inc. (RVPH) is a clinical-stage biopharmaceutical company primarily focused on discovering, developing, and commercializing next-generation therapeutics for diseases with significant unmet medical needs, particularly within the central nervous system (CNS), inflammatory, and cardiometabolic areas.

Groups RVPH belongs to

• Biotechnology
• Recent Reverse Splits
• Clinical Stage Biopharma
• Biopharmaceutical
• CNS Disorders
• Clinical Stage
• Healthcare
• Pharmaceuticals
• Unmet Medical Needs
• Neuroscience

RVPH financial model: income statement, cash flow and balance sheet